Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI8968 in Chronic Obstructive Pulmonary Disease
NCT01448850Phase 2Completed
- Sponsor
- MedImmune
- Start
- Nov 2011
- Primary completion
- Feb 2014
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 2 trial of AMG 108 in chronic obstructive pulmonary disease (COPD), sponsored by MedImmune. Started Nov 2011; status: completed.
02
Drugs
AMG 108
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01448850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01448850.